SKI Market

Indian Indices

Sensex

85,408.70 -116.14
( -0.14%)

Global Indices

Nasdaq

48,752.17 288.75
(0.60%)

Dow Jones

6,952.35 21.56
(0.31%)

Hang Seng

50,375.92 -36.95
(-0.07%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.57 -0.04
(-0.05%)

EUR-INR

105.52 0.34
(0.32%)

GBP-INR

120.86 0.52
(0.43%)

JPY-INR

0.57 0.00
(0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5631051

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

19.58

105693.42

EPS(TTM)

Face Value()

Div & Yield %

64.68

0.63

Back

Dr Reddy's Laboratories consolidated net profit rises 7.28% in the September 2025 quarter

Oct 25,2025

Net profit of Dr Reddy's Laboratories rose 7.28% to Rs 1347.10 crore in the quarter ended September 2025 as against Rs 1255.70 crore during the previous quarter ended September 2024. Sales rose 9.84% to Rs 8804.90 crore in the quarter ended September 2025 as against Rs 8016.10 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	8804.90	8016.10	10
OPM %	22.83	25.90	-
PBDT	2249.40	2314.40	-3
PBT	1744.80	1917.40	-9
NP	1347.10	1255.70	7

85,408.70 -116.14 ( -0.14%)

48,752.17 288.75 (0.60%)

6,952.35 21.56 (0.31%)

50,375.92 -36.95 (-0.07%)

9,870.68 -18.54 (-0.19%)

89.57 -0.04 (-0.05%)

105.52 0.34 (0.32%)

120.86 0.52 (0.43%)

0.57 0.00 (0.60%)